Clinical Trial Update: Aripiprazole, Abilify Maintena Collaborative Clinical Protocol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for aripiprazole (Abilify Maintena) collaboration protocol; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction

Drugs mentioned

• ABILIFY MAINTENA (ARIPIPRAZOLE)

Snippet

Sponsor: Gazda, Thomas D., M.D., PC | Conditions: Sexual Dysfunction | Phase 4 | Status: TERMINATED | Results posted: 2019-04-11